ASSET PURCHASE AGREEMENTAsset Purchase Agreement • July 16th, 2019 • Generex Biotechnology Corp • Pharmaceutical preparations • Florida
Contract Type FiledJuly 16th, 2019 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”) is dated July 11, 2019 (the “Execution Date”), by and between (i) Pantheon Medical - Foot & Ankle, LLC, a Delaware limited liability company (the “Seller”), and (ii) Generex Biotechnology Corporation, a Delaware corporation (“Parent”) and NuGenerex Distribution Solutions, LLC, a Delaware limited liability company (collectively, the “Buyer”). The Seller and the Buyer are referred to collectively herein as the “Parties” and each a “Party.”
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • July 16th, 2019 • Generex Biotechnology Corp • Pharmaceutical preparations • Florida
Contract Type FiledJuly 16th, 2019 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”) is dated July 11, 2019 (the “Execution Date”), by and between (i) Medisource Partners, LLC, a Texas limited liability company (the “Seller”), and (ii) Generex Biotechnology Corporation, a Delaware corporation (“Parent”) and NuGenerex Distribution Solutions, LLC, a Delaware limited liability company (collectively, the “Buyer”). The Seller and the Buyer are referred to collectively herein as the “Parties” and each a “Party.”
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • October 9th, 2018 • Generex Biotechnology Corp • Pharmaceutical preparations • Texas
Contract Type FiledOctober 9th, 2018 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”) is dated October 3, 2018 (the “Execution Date”), by and between Veneto Holdings, L.L.C., a Texas limited liability company (the “Seller”), and NuGenerex Distribution Solutions, LLC, a Delaware limited liability company (the “Buyer”). The Seller and the Buyer are referred to collectively herein as the “Parties” and each a “Party.”